Conference Nordic HPB - NOLCA, LUND

14 – 15 September 2023

Lecture hall “Aulan”

Thursday 14 September

08.30                  Registration

09.00                  Welcome

09.10 – 10.30      Updates Pancreas

Chair: Knut Jörgen Labori and Paulina Bereza-Carlsson

Biomarkers for early diagnosis in PDAC – novel tools (Daniel Ansari, Lund)

Surveillance after resection for PDAC – benefits and variability in guidelines (Bobby Tingstedt, Lund)

Extensive surgery (incl vascular resections) for PDAC – update and future aspects (Hanna Seppänen, Helsinki)

Neoadjuvant chemotherapy in upfront resectable PDAC. Outcome of Norpact 1 (Knut Jörgen Labori, Oslo)

10.30 – 10.50      Coffee/exhibition

10.50 – 12.30      Pro/Con

Chair: Frank Viborg Mortensen and Emil Östrand

Disappearing liver metastasis – resect or watch (Christian Sturesson, Stockholm/Kristoffer Brudvik, Oslo)

Neoadjuvant chemotherapy in resectable CRC liver mets – no/yes (Ville Sallinen, Helsinki/Jakob Eberhard)

Side-branch IPMNs – are present guidelines for management valid and relevant? Yes/no (Johanna Laukkarinen, Tampere/Kjetil Söreide, Stavanger)

Complications in PD – POPF: Warning signs? Scores? When to do rest pancreatectomy? Nordic survey. (Caroline Williamsson, Lund)

12.30 – 13.30      Lunch/exhibition

13.30 – 13.45      Presidential address (Roland Andersson, Lund)

13.45 – 14.05      Registry based research within HPB surgery – challenges and possibilities for Nordic collaborations (Bodil Andersson, Lund)

14.05 – 15.00      Nordic studies (Ongoing and new proposals from delegates)

Chair: Ville Sallinen and Bodil Andersson

15.00 - 15.30       Free papers/Young investigators (see separate information)

Chair: Oskar Hemmingsson and Bobby Tingstedt

15.30 – 15.50      Coffee/exhibition

15.50 – 17.00      Free papers/Young investigators (see separat information)

17.00 – 17.20      Most important HPB papers (Kjetil Söreide, Stavanger)

17.20 – 17.40      General Assembly of Nordic Chapter of IHPBA

19.30                  Dinner at AF-borgen, Sandgatan 2, Lund

Friday 15 September

Chair: Gerda Villadsen and Ulrik Carling

08.30 – 08.35      Welcome

08.35 – 08.55      Screening for HCC (Peter Jepsen, Aarhus)

08.55 - 09.20      Proton therapy of HCC (Britta Weber, Aarhus 

09.20 - 09.45      Selective Internal Radiotherapy of HCC (Daniel Alm and Inger Keussen, Stockholm)

09.45 – 10.10      Neoadjuvant treatment of HCC before resection or transplantation  (Hans-Christian Pommergaard, Copenhagen)

10.10 – 10.40      Coffee/ exhibition

Chair: Ville Sallinen and Merete Krogh

10.40 – 11.00      Socioeconomic inequities in HCC treatment and outcomes in Sweden (Juan Vaz, Halmstad/Lund)

11.00 – 11.25      Treatment of advanced cholangiocarcinoma (Pia Österlund, Helsinki)

11.25 – 11.40      Young investigator presentation no. 1: TOMCAT - a national protocol for cholangiocarcinoma (Anne Longva, Oslo)

11.40 – 11.55      Young investigator presentation no. 2: Technical efficacy and complications after ablation of hepatocellular carcinoma: a nationwide database study (Jeanett Klubien, Copenhagen)

11.55 - 12.10      Young investigator presentation no. 3: Prognostic genomic alterations in patients undergoing liver resection for hepatocellular carcinoma (Sophie Bull Nordkild, Copenhagen)

12.10 – 12.30      NOLCA General assembly

12.30 – 13.30      Lunch/exhibition

13.30 -14.00       Invited lecture: “Liver-on-a-chip” – possibilities and limitations in liver surgery (Aistè Kielaitè-Gulla, Vilnius)

14.00 – 15.00     Updates – Liver

Chair: Aisté  Kielaité-Gulla and Richard Fristedt

Any advantage of PVE and double vein embolization? (Anders Riegels Knudsen, Aarhus) 

ALPPS – update on outcome and indications (Per Sandström, Linköping)

Hepatic artery infusion (HAI) for CRC liver mets – evidence and studies (Excalibur) (Anne Longva, Oslo)

Decreased bleeding after hepatectomy following short term preoperative diet – evidence, mechanism, guidelines? (Jenny Rystedt, Lund)

15.00                  Summing up